GSK declares $0.4524/ADS or 17p/share dividend

What happened

GSK declared a third interim dividend of 17.00p per share for Q3 2026, up 6.3% from 16.00p a year earlier. This equals about $0.4524 per ADS, with payment on January 7, 2027, to holders of record November 13, 2026.

Confirmed

Global impact / market context

The higher payout means shareholders receive more cash per share than last year, while the company keeps less money for other uses. Because the amount matches prior quarters, the board is signaling steady returns rather than a one-time increase.

Analyst inference

Income-focused investors compare this 17p quarterly payout with the expected 70p full-year total when deciding whether to hold GSK shares or ADSs. The dividend reinvestment plan lets holders buy more shares instead of taking cash, which supports gradual position building.

Analyst inference

What to watch

1. Shareholders must own the stock before the ex-dividend dates of November 12, 2026, for ordinary shares and November 13, 2026, for ADSs to receive this payout. Confirmed
2. Ordinary shareholders who want to use the dividend reinvestment plan, which buys more shares with the cash, must submit their elections by December 14, 2026. Proposed
3. Watch whether GSK's later quarterly declarations keep the full-year total at 70p per share, since any cut or raise would change the cash investors expect to receive. Analyst inference

Evidence

• seekingalpha.com